Palliative sedation in a southern Appalachian community

Area of Science:

• Palliative Care Medicine
• Symptom Management
• End-of-Life Care

Background:

• Palliative sedation is a therapeutic option for refractory symptoms in end-of-life care.
• Understanding patient characteristics and outcomes associated with palliative sedation is crucial for optimizing care.
• Limited data exists on the specific profile and effectiveness of palliative sedation in diverse palliative care settings.

Purpose of the Study:

• To identify patient characteristics associated with the use of palliative sedation.
• To evaluate the duration, symptom control, and outcomes of palliative sedation.
• To analyze factors influencing the length of palliative sedation and patient survival.

Main Methods:

• Retrospective chart review of 1200 palliative care patients.
• Analysis of demographic, clinical, and treatment data for patients receiving palliative sedation.
• Comparison of characteristics between patients who received palliative sedation and those who did not.

Main Results:

• 28 out of 1200 patients received palliative sedation.
• Patients receiving sedation were more likely to have advanced cancer, poor performance status (ECOG ≥3), and short life expectancy.
• Common indications included delirium and dyspnea; 82% experienced symptom control, with a median sedation duration of 3 days.

Conclusions:

• Palliative sedation is utilized in a select group of palliative care patients with refractory symptoms and poor prognosis.
• The intervention is generally effective in symptom control, though duration varies.
• Further research can refine patient selection and optimize the use of palliative sedation for symptom relief.